TKB Critical Technologies 1 (NASDAQ:USCT) announced that it has postponed its extension vote to Friday, January 27 at 4:00 p.m. ET.
The special meeting, originally scheduled for yesterday, is being held to vote on an amendment to extend TKB’s completion deadline from January 29 to June 29.
The SPAC recently entered into a definitive agreement to combine with vehicle data tracker Wejo (NASDAQ:WEJO) on January 10. As you may recall, Wejo already completed a SPAC transaction with Virtuoso Acquisition Corp. in November 2021, marking the target company’s 2nd SPAC deal.
Manchester, UK-based Wejo has developed a data analysis suite based on tracking connected cars for a wide array of clients seeking predictive intelligence of vehicle ownership, traffic flows and more.
Armada I (NASDAQ:AACI) announced this afternoon that it has once again postponed its extension vote. The SPAC initially planned to hold its special meeting on January 20, but postponed it to January 30, and will now be pushing it back until tomorrow, January 31. Armada has also extended the deadline for holders to submit their public...
Prime Impact I (NYSE:PIAI) has entered into a definitive agreement to combine with auto insurance firm Cheche at an enterprise value of $841 million, or about 2.3x its 2022 revenue. Beijing-based Cheche provides a digital insurance platform for car owners in China with about 34 million vehicles covered. The combined company is expected to trade...
Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. Latest SPAC News: Hambro Perks eyes merger with Biotech Istesso, Rocket Lab launches first vehicle from U.S. soil, and Alliance Entertainment signs licensing agreement with The Walt Disney Company Hambro Perks SPAC Eyes Merger With Biotech...
Pono Capital Corp. (NASDAQ:PONO) disclosed in an 8-K filing this morning that its shareholders approved its combination with air mobility company AERWINS at a special meeting held on Friday, January 27. Holders of 12,412,861 common shares were present at the meeting and the deal was approved with 11,218,712 shares in favor of the transaction. The filing did not...
European Biotech (NASDAQ:EBAC) announced in an 8-K this morning that it has increased its PIPE by $7.8 million and added $7 million to the convertible loans attached to the combination with biotech firm Oculis. The new PIPE cash comes at $10 per share and joins $63.3 million in existing PIPE financing for a total of...